Condition: Major Depressive Disorder · Sponsor: Definium Therapeutics US, Inc.
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - Ascend
This description comes directly from the study's public registry record.
Definium Therapeutics Clinical Trials Info Requests · 1-332-282-0479 · clinicaltrials@definiumtx.com
Always discuss trial participation with your own doctor first.
| Lighthouse Psychiatry | Gilbert, Arizona, United States | Withdrawn |
| Preferred Research Partners, Inc. | Little Rock, Arkansas, United States | Recruiting |
| ATP Clinical Research Orange County | Orange, California, United States | Not Yet Recruiting |
| Kadima Neuropsychiatry Institute | San Diego, California, United States | Not Yet Recruiting |
| UCSF Department of Neurology | San Francisco, California, United States | Not Yet Recruiting |
| Psychedelic Science Institute | Santa Monica, California, United States | Recruiting |
| Mountain View Clinical Research, Inc | Denver, Colorado, United States | Recruiting |
| Clinical Neuroscience Solutions, Inc (Jacksonville) | Jacksonville, Florida, United States | Not Yet Recruiting |
| K2 Medical Research (Maitland) | Maitland, Florida, United States | Not Yet Recruiting |
| Clinical Neuroscience Solutions, Inc (Orlando) | Orlando, Florida, United States | Not Yet Recruiting |
| Charter Research | Orlando, Florida, United States | Not Yet Recruiting |
| K2 Medical Research (Tampa) | Tampa, Florida, United States | Not Yet Recruiting |
+ 20 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.